Table 1.
Characteristics of patients in the RD vs Control primary endpoint analysis.
| Controls (n = 77) | RICT/RD (n = 124) | p-value | |
|---|---|---|---|
| Gender F/M – n (%) | 36 (47)/41 (53) | 55 (44)/69 (56) | NS |
| Median age at Inclusion, years (min–max) | 63 (51–70) | 63 (51–71) | NS |
| Risk group IR/HR – n (%) | 50 (65)/27 (35) | 68 (55)/56 (45) | NS |
| Median time from diagnosis to inclusion, days (min–max) | 64 (32–256) | 64 (29–319) | NS |
| Given therapy | |||
| Chemotherapy only | 69 | 27 | |
| Transplanted | 8a | 97b | |
| Median time from inclusion to transplant, days (min–max) | 73 (23–236) | ||
| Causes of death – n (%) | 0.003 | ||
| GvHD or related infection | – | 9 (7) | |
| Infection | 1 (1) | 11 (9) | |
| Other | 3 (4) | 4 (3) | |
| Relapse | 50 (65) | 54 (44) | |
| Secondary malignancy | 3 (4) | 3 (2) | |
a6 URD, 1 cord blood, 1 haploidentical HCT.
bAll RICT/RD.